MedPath

Skelaxin

Approved
Approval ID

d8684144-6c2d-4664-943a-2d3d2b46b1fc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 3, 2011

Manufacturers
FDA

Preferred Pharmaceuticals, Inc

DUNS: 791119022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Metaxalone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68788-0881
Application NumberNDA013217
Product Classification
M
Marketing Category
C73594
G
Generic Name
Metaxalone
Product Specifications
Route of AdministrationORAL
Effective DateJuly 21, 2010
FDA Product Classification

INGREDIENTS (5)

CALCIUMInactive
Code: SY7Q814VUP
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
ALGINIC ACIDInactive
Code: 8C3Z4148WZ
Classification: IACT
METAXALONEActive
Quantity: 800 mg in 1 1
Code: 1NMA9J598Y
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Skelaxin - FDA Drug Approval Details